Russia says unnamed U.S. firm violated patent rights on Sputnik V vaccine

Health News
FILE PHOTO: Vials labelled “Sputnik V Coronavirus COVID-19 Vaccine” and a syringe are seen in front of a displayed Sputnik V logo, in this illustration photo taken March 12, 2021. REUTERS/Dado Ruvic/Illustration

MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund said on Monday a U.S. firm had violated Russian patent rights on its Sputnik V vaccine against COVID-19.

RDIF, which actively markets Sputnik V abroad, did not disclose the name of the U.S. firm.

Source: Read Full Article

Related posts:

First COVID-19 vaccines arrive in Japan from Pfizer: media Georgia limits AstraZeneca shots after nurse dies of anaphylactic shock: TASS French mask producers seek protective shield once pandemic over J&J applies for COVID-19 vaccine emergency authorisation from South Africa Spain prepares to extends use of AstraZeneca vaccine to 18-65 year olds: media
, , , , , , ,